Starling Oncology Statistics
Total Valuation
STLN has a market cap or net worth of $647.17 million. The enterprise value is $710.87 million.
| Market Cap | 647.17M |
| Enterprise Value | 710.87M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STLN has 101.92 million shares outstanding. The number of shares has increased by 25.63% in one year.
| Current Share Class | 101.92M |
| Shares Outstanding | 101.92M |
| Shares Change (YoY) | +25.63% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 12.78% |
| Owned by Institutions (%) | 49.35% |
| Float | 88.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | 0.85 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1,973.07 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.36
| Current Ratio | 1.36 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.65% |
| Return on Invested Capital (ROIC) | -30.31% |
| Return on Capital Employed (ROCE) | -31.32% |
| Weighted Average Cost of Capital (WACC) | 6.55% |
| Revenue Per Employee | $916,137 |
| Profits Per Employee | -$47,680 |
| Employee Count | 641 |
| Asset Turnover | 3.47 |
| Inventory Turnover | 27.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +82.47% in the last 52 weeks. The beta is 0.44, so STLN's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +82.47% |
| 50-Day Moving Average | 6.11 |
| 200-Day Moving Average | 4.41 |
| Relative Strength Index (RSI) | 49.00 |
| Average Volume (20 Days) | 1,327,047 |
Short Selling Information
The latest short interest is 7.05 million, so 6.92% of the outstanding shares have been sold short.
| Short Interest | 7.05M |
| Short Previous Month | 6.82M |
| Short % of Shares Out | 6.92% |
| Short % of Float | 7.94% |
| Short Ratio (days to cover) | 6.38 |
Income Statement
In the last 12 months, STLN had revenue of $587.24 million and -$30.56 million in losses. Loss per share was -$0.30.
| Revenue | 587.24M |
| Gross Profit | 92.17M |
| Operating Income | -26.09M |
| Pretax Income | -36.29M |
| Net Income | -30.56M |
| EBITDA | -19.28M |
| EBIT | -26.09M |
| Loss Per Share | -$0.30 |
Balance Sheet
The company has $41.09 million in cash and $104.79 million in debt, with a net cash position of -$63.70 million or -$0.63 per share.
| Cash & Cash Equivalents | 41.09M |
| Total Debt | 104.79M |
| Net Cash | -63.70M |
| Net Cash Per Share | -$0.63 |
| Equity (Book Value) | -24.91M |
| Book Value Per Share | -0.25 |
| Working Capital | 34.05M |
Cash Flow
In the last 12 months, operating cash flow was $328,000 and capital expenditures -$3.61 million, giving a free cash flow of -$3.29 million.
| Operating Cash Flow | 328,000 |
| Capital Expenditures | -3.61M |
| Depreciation & Amortization | 6.81M |
| Net Borrowing | -1.13M |
| Free Cash Flow | -3.29M |
| FCF Per Share | -$0.03 |
Margins
Gross margin is 15.69%, with operating and profit margins of -4.44% and -6.18%.
| Gross Margin | 15.69% |
| Operating Margin | -4.44% |
| Pretax Margin | -6.18% |
| Profit Margin | -6.18% |
| EBITDA Margin | -3.28% |
| EBIT Margin | -4.44% |
| FCF Margin | n/a |
Dividends & Yields
STLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -25.63% |
| Shareholder Yield | -25.63% |
| Earnings Yield | -4.72% |
| FCF Yield | -0.51% |
Analyst Forecast
The average price target for STLN is $9.00, which is 41.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 41.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 31.36% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STLN has an Altman Z-Score of 1.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 4 |